2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594

2013 ACCF/AHA Guideline for the Management of Heart Failure

Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418

2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H. M., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.011 · Cited by 3,380

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H. M., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000503 · Cited by 2,544

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy

Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., Iung, B., Johnson, M. R., Kintscher, U., Kranke, P., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy340 · Cited by 2,292

2013 ACCF/AHA Guideline for the Management of Heart Failure

Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T. B., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8776 · Cited by 2,213

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,116

Subclinical atrial fibrillation and the risk of stroke

Healey, J. S., Connolly, S. J., Gold, M. R., Israel, C. W., Van Gelder, I. C., Capucci, A., Lau, C. P., Fain, E., Yang, S., Bailleul, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105575 · Cited by 2,100

Assessing the Effects of Physician-Patient Interactions on the Outcomes of Chronic Disease

Kaplan, S. H., Greenfield, S., & Ware, J. E. (1989) · Medical Care · doi:10.1097/00005650-198903001-00010 · Cited by 2,043

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.010 · Cited by 1,896

Expanding Patient Involvement in Care

Greenfield, S., Kaplan, S. H., & Ware, J. E. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-4-520 · Cited by 1,459

New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy

Semsarian, C., Ingles, J., Maron, M. S., & Maron, B. J. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.01.019 · Cited by 1,405

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.011 · Cited by 1,276

Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy

Maron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)

O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht439 · Cited by 1,251

Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic Cardiomyopathy

Spirito, P., Bellone, P., Harris, K. M., Bernabò, P., Bruzzi, P., & Maron, B. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422403 · Cited by 1,142

Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction

Maron, M. S., Olivotto, I., Zenovich, A. G., Link, M. S., Pandian, N. G., Kuvin, J. T., Nistri, S., Cecchi, F., Udelson, J. E., & Maron, B. J. (2006) · Circulation · doi:10.1161/circulationaha.106.644682 · Cited by 1,127

Patients’ participation in medical care

Greenfield, S., Kaplan, S. H., Ware, J. E., Yano, E. M., & Frank, H. J. L. (1988) · Journal of General Internal Medicine · doi:10.1007/bf02595921 · Cited by 1,117

Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy

Chan, R. H., Maron, B. J., Olivotto, I., Pencina, M. J., Assenza, G. E., Haas, T., Lesser, J. R., Gruner, C., Crean, A. M., Rakowski, H., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.007094 · Cited by 962

Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)

Ho, C. Y., Day, S. M., Ashley, E. A., Michels, M., Pereira, A. C., Jacoby, D., Cirino, A. L., Fox, J. C., Lakdawala, N. K., Ware, J. S., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.033200 · Cited by 860

A Prospective Study of Sudden Cardiac Death among Children and Young Adults

Bagnall, R. D., Weintraub, R. G., Ingles, J., Duflou, J. A., Yeates, L., Lam, L., Davis, A. M., Thompson, T. N., Connell, V., Wallace, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1510687 · Cited by 847

Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review

Wigle, E. D., Sasson, Z., Henderson, M. A., Ruddy, T. D., Fulop, J. C., Rakowski, H., & Williams, W. G. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(85)90024-6 · Cited by 822

Long-Term Effects of Surgical Septal Myectomy on Survival in Patients With Obstructive Hypertrophic Cardiomyopathy

Ommen, S. R., Maron, B. J., Olivotto, I., Maron, M. S., Cecchi, F., Betocchi, S., Gersh, B. J., Ackerman, M. J., McCully, R. B., Dearani, J. A., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.090 · Cited by 812

Genetic Misdiagnoses and the Potential for Health Disparities

Manrai, A. K., Funke, B. H., Rehm, H. L., Olesen, M. S., Maron, B. A., Szolovits, P., Margulies, D. M., Loscalzo, J., & Kohane, I. S. (2016) · New England Journal of Medicine · doi:10.1056/nejmsa1507092 · Cited by 808

Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy

Maron, B. J., Spirito, P., Shen, W.-K., Haas, T. S., Formisano, F., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Lawrenz, T., et al. (2007) · JAMA · doi:10.1001/jama.298.4.405 · Cited by 802

Patient participation in decision-making

Guadagnoli, E., & Ward, P. (1998) · Social Science & Medicine · doi:10.1016/s0277-9536(98)00059-8 · Cited by 795

Comparison of β-Blockers, Amiodarone Plus β-Blockers, or Sotalol for Prevention of Shocks From Implantable Cardioverter Defibrillators<SUBTITLE>The OPTIC Study: A Randomized Trial</SUBTITLE>

Connolly, S. J. (2006) · JAMA · doi:10.1001/jama.295.2.165 · Cited by 788

Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy

Olivotto, I., Cecchi, F., Casey, S. A., Dolara, A., Traverse, J. H., & Maron, B. J. (2001) · Circulation · doi:10.1161/hc4601.097997 · Cited by 745

Genetics of Hypertrophic Cardiomyopathy After 20 Years

Maron, B. J., Maron, M. S., & Semsarian, C. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.068 · Cited by 702

ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography

Douglas, P. S., Garcia, M. J., Haines, D. E., Lai, W. W., Manning, W. J., Patel, A. R., Picard, M. H., Polk, D. M., Ragosta, M., Ward, R. P., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.002 · Cited by 681

Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy

Harris, K. M., Spirito, P., Maron, M. S., Zenovich, A. G., Formisano, F., Lesser, J. R., Mackey‐Bojack, S., Manning, W. J., Udelson, J. E., & Maron, B. J. (2006) · Circulation · doi:10.1161/circulationaha.105.583500 · Cited by 665

Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients

Klues, H. G., Schiffers, A., & Maron, B. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00390-8 · Cited by 653

Hypertrophic Cardiomyopathy

Maron, B. J., Ommen, S. R., Semsarian, C., Spirito, P., Olivotto, I., & Maron, M. S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.003 · Cited by 652

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy

Ommen, S. R., Mital, S. R., Burke, M. A., Day, S. M., Deswal, A. M., Elliot, P. M., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P. F., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000937 · Cited by 641

Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT

Gelder, I. C. V., Healey, J. S., Crijns, H. J. G. M., Wang, J., Hohnloser, S. H., Gold, M. R., Capucci, A., Lau, C., Morillo, C. A., Hobbelt, A. H., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx042 · Cited by 604

2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H., Conti, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000311 · Cited by 595

Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy

Rickers, C., Wilke, N. M., Jerosch‐Herold, M., Casey, S. A., Panse, P. M., Panse, N., Weil, J., Zenovich, A. G., & Maron, B. J. (2005) · Circulation · doi:10.1161/circulationaha.104.507723 · Cited by 581

Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy

Monserrat, L., Elliott, P. M., Gimeno, J. R., Sharma, S., Penas-Lado, M., & McKenna, W. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00827-1 · Cited by 541

Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy

Elliot, P. M., Gimeno, J. R., Mahon, N., Poloniecki, J. D., & McKenna, W. J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04005-8 · Cited by 517

Hypertrophic Cardiomyopathy Phenotype Revisited After 50 Years With Cardiovascular Magnetic Resonance

Maron, M. S., Maron, B. J., Harrigan, C. J., Buros, J., Gibson, C. M., Olivotto, I., Biller, L. H., Lesser, J. R., Udelson, J. E., Manning, W. J., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.006 · Cited by 501

Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study

Maron, B. J., Savage, D. D., Wolfson, J. K., & Epstein, S. E. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90604-4 · Cited by 494

Assessment of Permanent Dual-Chamber Pacing as a Treatment for Drug-Refractory Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy

Maron, B. J., Nishimura, R. A., McKenna, W. J., Rakowski, H., Josephson, M. E., & Kieval, R. S. (1999) · Circulation · doi:10.1161/01.cir.99.22.2927 · Cited by 490

Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

Charron, P., Arad, M., Arbustini, E., Basso, C., Bilińska, Z. T., Elliot, P. M., Heliö, T. M., Keren, A., McKenna, W. J., Monserrat, L., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq271 · Cited by 486

Prognostic Value of LGE-CMR in HCM

Weng, Z., Yao, J., Chan, R. H. M., He, J., Yang, X., Zhou, Y., & He, Y. (2016) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2016.02.031 · Cited by 482

2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000499 · Cited by 463

Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry

Lambiase, P. D., Barr, C. S., Theuns, D. A. M. J., Knops, R. E., Neužil, P., Johansen, J. B., Hood, M., Pedersen, S. S., Kääb, S., MURGATROYD, F. D., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu112 · Cited by 461

Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC)

Pelliccia, A., Solberg, E. E., Papadakis, M., Adami, P. E., Biffi, A., Caselli, S., Gerche, A. L., Niebauer, J., Preßler, A., Schmied, C. M., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy730 · Cited by 447

Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography

Moon, J., Fisher, N. G., McKenna, W. J., & Pennell, D. J. (2004) · Heart · doi:10.1136/hrt.2003.014969 · Cited by 439

Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes

Ingles, J., Goldstein, J., Thaxton, C., Caleshu, C. A., Corty, E. W., Crowley, S. B., Dougherty, K. E., Harrison, S. M., McGlaughon, J., Milko, L. V., et al. (2019) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.119.002460 · Cited by 434

Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update

Porter, T. R., Mulvagh, S. L., Abdelmoneim, S. S., Becher, H. H., Belcik, J. T., Bierig, M., Choy, J. B., Gaibazzi, N., Gillam, L. D., Janardhanan, R., et al. (2018) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2017.11.013 · Cited by 432

Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)

Boriani, G., Glotzer, T. V., Santini, M., West, T. M., De Melis, M., Sepsi, M., Gasparini, M., Lewalter, T., Camm, J. A., & Singer, D. E. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht491 · Cited by 427

Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity

Alfares, A. A., Kelly, M. A., McDermott, G., Funke, B. H., Lebo, M. S., Baxter, S. B., Shen, J., McLaughlin, H. M., Clark, E. H., Babb, L. J., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.205 · Cited by 412

Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy

Sherrid, M. V., Barac, I., McKenna, W. J., Elliott, P. M., Dickie, S., Chojnowska, L., Casey, S., & Maron, B. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.012 · Cited by 410

Shared Genetic Causes of Cardiac Hypertrophy in Children and Adults

Morita, H., Rehm, H. L., Menesses, A., McDonough, B. A., Roberts, A. E., Kucherlapati, R., Towbin, J. A., Seidman, J. G., & Seidman, C. E. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa075463 · Cited by 404

Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy

Maron, B. J., Olivotto, I., Bellone, P., Conte, M. R., Cecchi, F., Flygenring, B., Casey, S. A., Gohman, T. E., Bongioanni, S., & Spirito, P. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01727-2 · Cited by 396

Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy.

Bonow, R. O., Rosing, D. R., Bacharach, S. L., Green, M. V., Kent, K. M., Lipson, L. C., Maron, B. J., Leon, M. B., & Epstein, S. E. (1981) · Circulation · doi:10.1161/01.cir.64.4.787 · Cited by 393

Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling

Ingles, J., Doolan, A., Chiu, C., Seidman, J. G., Seidman, C. E., & Semsarian, C. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.033886 · Cited by 385

Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events

BOTTO, G. L., PADELETTI, L., SANTINI, M., CAPUCCI, A., GULIZIA, M., ZOLEZZI, F., FAVALE, S., MOLON, G., RICCI, R., BIFFI, M., et al. (2009) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01320.x · Cited by 380

Dual-Chamber Pacing for Hypertrophic Cardiomyopathy: A Randomized, Double-Blind, Crossover Trial

Nishimura, R. A., Trusty, J. M., Hayes, D. L., Ilstrup, D. M., Larson, D. R., Hayes, S. N., Allison, T. G., & Tajik, A. J. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00473-1 · Cited by 376

Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm

Rowin, E. J., Maron, B. J., Haas, T. S., Garberich, R., Wang, W., Link, M. S., & Maron, M. S. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.063 · Cited by 369

Syncope and risk of sudden death in hypertrophic cardiomyopathy

Spirito, P., Autore, C., Rapezzi, C., Bernabò, P., Badagliacca, R., Maron, M. S., Bongioanni, S., Coccolo, F., Estes, N. A. M., Barillà, C. S., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.798314 · Cited by 365

Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review

Guttmann, O. P., Rahman, M. S., O’Mahony, C., Anastasakis, A., & Elliot, P. M. (2013) · Heart · doi:10.1136/heartjnl-2013-304276 · Cited by 357

Patterns of Disease Progression in Hypertrophic Cardiomyopathy

Olivotto, I., Cecchi, F., Poggesi, C., & Yacoub, M. H. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.967026 · Cited by 352

American Society of Echocardiography Clinical Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy

Nagueh, S. F., Bierig, S. M., Budoff, M. J., Desai, M. Y., Dilsizian, V., Eidem, B. W., Goldstein, S. A., Hung, J., Maron, M. S., Ommen, S. R., et al. (2011) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2011.03.006 · Cited by 346

Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy

Faber, L., Seggewiß, H., & Gleichmann, U. (1998) · Circulation · doi:10.1161/01.cir.98.22.2415 · Cited by 346

Clinical Outcome and Phenotypic Expression in LAMP2 Cardiomyopathy

Maron, B. J. (2009) · JAMA · doi:10.1001/jama.2009.371 · Cited by 343

Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy

Woo, A., Williams, W. G., Choi, R., Wigle, E. D., Rozenblyum, E., Fedwick, K., Siu, S. C., Ralph-Edwards, A. C., & Rakowski, H. (2005) · Circulation · doi:10.1161/01.cir.0000162460.36735.71 · Cited by 334

Evaluation of Left Ventricular Filling Pressures by Doppler Echocardiography in Patients With Hypertrophic Cardiomyopathy

Geske, J. B., Sorajja, P., Nishimura, R. A., & Ommen, S. R. (2007) · Circulation · doi:10.1161/circulationaha.107.698985 · Cited by 328

2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope

Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.003 · Cited by 327

Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy

Maron, M. S., Rowin, E. J., Wessler, B. S., Mooney, P., Fatima, A., Patel, P. P., Koethe, B. C., Romashko, M. D., Link, M. S., & Maron, B. J. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.1391 · Cited by 323

Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A two-dimensional echocardiographic study

Shapiro, L. M., & McKenna, W. J. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80269-1 · Cited by 322

Hospital Volume Outcomes After Septal Myectomy and Alcohol Septal Ablation for Treatment of Obstructive Hypertrophic Cardiomyopathy

Kim, L. K., Swaminathan, R. V., Looser, P. M., Minutello, R. M., Wong, S. C., Bergman, G. W., Naidu, S. S., Gade, C. L., Charitakis, K., Singh, H. S., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.0252 · Cited by 304

Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy

Sorajja, P., Valeti, U. S., Nishimura, R. A., Ommen, S. R., Rihal, C. S., Gersh, B. J., Hodge, D. O., Schaff, H. V., & Holmes, D. R. (2008) · Circulation · doi:10.1161/circulationaha.107.738740 · Cited by 303

Pacing in hypertrophic obstructive cardiomyopathy: A randomized crossover study

KAPPENBERGER, L. J., Linde, C. M., Daubert, C., McKenna, W. J., Meisel, E., Sadoul, N., Chojnowska, L., Guize, L., Gras, D., Jeanrenaud, X., et al. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015435 · Cited by 295

Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy

Sorajja, P., Ommen, S. R., Holmes, D. R., Dearani, J. A., Rihal, C. S., Gersh, B. J., Lennon, R. J., & Nishimura, R. A. (2012) · Circulation · doi:10.1161/circulationaha.111.076257 · Cited by 293

Sudden cardiac death in the young: the molecular autopsy and a practical approach to surviving relatives

Semsarian, C., Ingles, J., & Wilde, A. A. M. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv063 · Cited by 292

Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic Cardiomyopathy

Maron, B. J., Spirito, P., Ackerman, M. J., Casey, S. A., Semsarian, C., Estes, N. A. M., Shannon, K. M., Ashley, E. A., Day, S. M., Pacileo, G., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.037 · Cited by 288

Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Results of a Prospective, Multinational Registry

Lampert, R., Olshansky, B., Heidbuchel, H., Lawless, C., Saarel, E., Ackerman, M., Calkins, H., Estes, N. A. M., Link, M. S., Maron, B. J., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000447 · Cited by 286

Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis

Mahajan, R., Perera, T., Elliott, A. D., Twomey, D. J., Kumar, S. K., Munwar, D. A., Khokhar, K. B., Thiyagarajah, A., Middeldorp, M. E., Nalliah, C. J., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx731 · Cited by 279

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High‐Risk Population

Siontis, K. C., Geske, J. B., Ong, K., Nishimura, R. A., Ommen, S. R., & Gersh, B. J. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001002 · Cited by 276

The Mitral Valve in Obstructive Hypertrophic Cardiomyopathy

Sherrid, M. V., Balaram, S. K., Kim, B., Axel, L., & Swistel, D. G. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.071 · Cited by 276

Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy

Adabag, A. S., Casey, S. A., Kuskowski, M. A., Zenovich, A. G., & Maron, B. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.043 · Cited by 273

The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms

Autore, C., Bernabò, P., Barillà, C. S., Bruzzi, P., & Spirito, P. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.12.067 · Cited by 263

Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy

Rowin, E. J., Hausvater, A., Link, M. S., Abt, P., Gionfriddo, W., Wang, W., Rastegar, H., Estes, N. A. M., Maron, M. S., & Maron, B. J. (2017) · Circulation · doi:10.1161/circulationaha.117.029267 · Cited by 262

Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy

Elliot, P. M., Sharma, S., Varnava, A. M., Poloniecki, J. D., Rowland, E., & McKenna, W. J. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00056-x · Cited by 257

Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy

Shah, J., Esteban, M. T. T., Thaman, R., Sharma, R., Mist, B., Pantazis, A. A., Ward, D., Kohli, S. K., Page, S. P., Demetrescu, C. D., et al. (2007) · Heart · doi:10.1136/hrt.2007.126003 · Cited by 257

Dual-Chamber Versus Single-Chamber Detection Enhancements for Implantable Defibrillator Rhythm Diagnosis

Friedman, P. A., McClelland, R. L., Bamlet, W. R., Acosta, H., Kessler, D. J., Munger, T. M., Kavesh, N. G., Wood, M., Daoud, E. G., Massumi, A., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.594531 · Cited by 255

Device-detected subclinical atrial tachyarrhythmias: definition, implications and management—an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

Görenek, B., Bax, J. J., Boriani, G., Chen, S., Dagres, N., Glotzer, T. V., Healey, J. S., Israel, C. W., Kudaiberdieva, G., Levin, L., et al. (2017) · EP Europace · doi:10.1093/europace/eux163 · Cited by 249

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.

Rosing, D. R., Kent, K. M., Maron, B. J., & Epstein, S. E. (1979) · Circulation · doi:10.1161/01.cir.60.6.1208 · Cited by 244

Effect of Moderate-Intensity Exercise Training on Peak Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy: A Randomized Clinical Trial

Saberi, S., Wheeler, M., Bragg-Gresham, J., Hornsby, W., Agarwal, P. P., Attili, A., Concannon, M., Dries, A. M., Shmargad, Y., Salisbury, H., et al. (2017) · JAMA · doi:10.1001/jama.2017.2503 · Cited by 241

Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function

Mentias, A. G., Raeisi‐Giglou, P., Smedira, N. G., Feng, K., Sato, K., Wazni, O. M., Kanj, M., Flamm, S. D., Thamilarasan, M., Popović, Z., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.060 · Cited by 240

Atrial fibrillation in hypertrophie cardiomyopathy: A longitudinal study

Robinson, K., Frenneaux, M. P., Stockins, B., Karatasakis, G., Poloniecki, J. D., & Mckenna, W. J. (1990) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80014-2 · Cited by 237

Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: Clarification of pathophysiology and importance in intraoperative decision making

Grigg, L., Wigle, E. D., Williams, W. G., Daniel, L. B., & Rakowski, H. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90135-a · Cited by 234

Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy

Melacini, P., Basso, C., Angelini, A., Calore, C., Bobbo, F., Tokajuk, B., Bellini, N., Smaniotto, G., Zucchetto, M., Iliceto, S., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq136 · Cited by 234

A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy

Miron, A., Lafrenière‐Roula, M., Fan, C. S., Armstrong, K. R., Dragulescu, A., Papaz, T., Manlhiot, C., Kaufman, B. D., Butts, R. J., Gardin, L., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.047235 · Cited by 225

Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the American College of Medical Genetics and Genomics (ACMG)

Deignan, J. L., Chung, W. K., Kearney, H. M., Monaghan, K. G., Rehder, C. W., & Chao, E. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0478-1 · Cited by 224

Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Insights From the SHaRe Registry

Marstrand, P., Han, L., Day, S. M., Olivotto, I., Ashley, E. A., Michels, M., Pereira, A. C., Wittekind, S. G., Helms, A., Saberi, S., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044366 · Cited by 219

Hemodynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs∗

D, E. B. M., & Ebert, P. A. (1962) · The American Journal of Cardiology · doi:10.1016/0002-9149(62)90373-9 · Cited by 217

Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery11Supported, in part, by grant NCC9-60 from the National Aeronautics and Space Administration, Houston, Texas, Grant #9951522V from the America Heart Association Ohio Local Chapter, Columbus, Ohio and Grant #R01 HL56688-01A1 from the National Institutes of Health, Bethesda, Maryland.22Presented, in part, at the 49th Annual Scientific Sessions of American College of Cardiology, March 2000, Anaheim, California.

Xin, J., Shiota, T., Lever, H. M., Kapadia, S. R., Sitges, M., Rubin, D. N., Bauer, F., Greenberg, N. L., Agler, D. A., Drinko, J. K., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01656-4 · Cited by 211

Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy

Patel, P., Dhillon, A. S., Popović, Z., Smedira, N. G., Rizzo, J., Thamilarasan, M., Agler, D. A., Lytle, B. W., Lever, H. M., & Desai, M. Y. (2015) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.115.003132 · Cited by 207

Amelioration of Angina Pectoris in Idiopathic Hypertrophic Subaortic Stenosis with Beta-Adrenergic Blockade

Cohen, L. S., & Braunwald, E. (1967) · Circulation · doi:10.1161/01.cir.35.5.847 · Cited by 204

Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy

McLeod, C. J., Ommen, S. R., Ackerman, M. J., Weivoda, P. L., Shen, W.-K., Dearani, J. A., Schaff, H. V., Tajik, A. J., & Gersh, B. J. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm117 · Cited by 203

International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM)

O’Mahony, C., Jichi, F., Ommen, S. R., Christiaans, I., Arbustini, E., Garcia-Pavia, P., Cecchi, F., Olivotto, I., Kitaoka, H., Gotsman, I., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.030437 · Cited by 201

Risk associated with pregnancy in hypertrophic cardiomyopathy

Autore, C., Conte, M. R., Piccininno, M., Bernabò, P., Bonfiglio, G., Bruzzi, P., & Spirito, P. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02495-6 · Cited by 199

Adverse Prognosis of Patients With Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease

Sorajja, P., Ommen, S. R., Nishimura, R. A., Gersh, B. J., Berger, P. B., & Tajik, A. J. (2003) · Circulation · doi:10.1161/01.cir.0000097110.55312.bf · Cited by 198

Predictors of Long-Term Outcomes in Symptomatic Hypertrophic Obstructive Cardiomyopathy Patients Undergoing Surgical Relief of Left Ventricular Outflow Tract Obstruction

Desai, M. Y., Bhonsale, A., Smedira, N. G., Naji, P., Thamilarasan, M., Lytle, B. W., & Lever, H. M. (2013) · Circulation · doi:10.1161/circulationaha.112.000849 · Cited by 193

Left Ventricular Assist Device Therapy in Patients With Restrictive and Hypertrophic Cardiomyopathy

Topilsky, Y., Pereira, N. L., Shah, D. K., Boilson, B. A., Schirger, J. A., Kushwaha, S. S., Joyce, L. D., & Park, S. J. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.959288 · Cited by 192

Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic Cardiomyopathy

Bagnall, R. D., Ingles, J., Dinger, M. E., Cowley, M. J., Ross, S. B., Minoche, A. E., Lal, S., Turner, C., Colley, A., Rajagopalan, S., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.078 · Cited by 192

Mitral Regurgitation in Patients With Hypertrophic Obstructive Cardiomyopathy

Hong, J. H., Schaff, H. V., Nishimura, R. A., Abel, M. D., Dearani, J. A., Li, Z., & Ommen, S. R. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.07.735 · Cited by 191

Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy

Kwon, D. H., Setser, R. M., Thamilarasan, M., Popović, Z., Smedira, N. G., Schoenhagen, P., Garcia, M. J., Lever, H. M., & Desai, M. Y. (2007) · Heart · doi:10.1136/hrt.2007.118018 · Cited by 188

Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis of randomized controlled trials

Santangeli, P., Muser, D., Maeda, S., Filtz, A., Zado, E. S., Frankel, D. S., Dixit, S., Epstein, A. E., Callans, D. J., & Marchlinski, F. E. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.03.004 · Cited by 184

Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy

Ismail, T. F., Jabbour, A., Gulati, A., Mallorie, A., Raza, S., Cowling, T. E., Das, B., Khwaja, J., Alpendurada, F., Wage, R., et al. (2014) · Heart · doi:10.1136/heartjnl-2013-305471 · Cited by 183

Low Operative Mortality Achieved With Surgical Septal Myectomy

Maron, B. J., Dearani, J. A., Ommen, S. R., Maron, M. S., Schaff, H. V., Nishimura, R. A., Ralph-Edwards, A., Rakowski, H., Sherrid, M. V., Swistel, D. G., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.1333 · Cited by 183

Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction

Rowin, E. J., Maron, B. J., Carrick, R. T., Patel, P. P., Koethe, B. C., Wells, S. B., & Maron, M. S. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.045 · Cited by 183

Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence

Spoladore, R., Maron, M. S., D’Amato, R., Camici, P. G., & Olivotto, I. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs150 · Cited by 181

Treatment of Obstructive Hypertrophic Cardiomyopathy Symptoms and Gradient Resistant to First-Line Therapy With β-Blockade or Verapamil

Sherrid, M. V., Shetty, A., Winson, G., Kim, B., Musat, D., Alviar, C. L., Homel, P., Balaram, S. K., & Swistel, D. G. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.000122 · Cited by 178

Obesity and its Association to Phenotype and Clinical Course in Hypertrophic Cardiomyopathy

Olivotto, I., Maron, B. J., Tomberli, B., Appelbaum, E. A., Salton, C. J., Haas, T. S., Gibson, C. M., Nistri, S., Servettini, E., Chan, R. H. M., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.062 · Cited by 174

The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy

O’Mahony, C., Lambiase, P. D., Quarta, G., Cardona, M., Calcagnino, M. M., Tsovolas, K., Al-Shaikh, S., Rahman, S. M., Arnous, S., Jones, S., et al. (2011) · Heart · doi:10.1136/hrt.2010.217182 · Cited by 174

Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies

Maron, B. J., Rowin, E. J., Casey, S. A., Lesser, J. R., Garberich, R., McGriff, D. M., & Maron, M. S. (2015) · Circulation · doi:10.1161/circulationaha.115.017633 · Cited by 172

Long-Term Survival in Patients With Resting Obstructive Hypertrophic Cardiomyopathy

Ball, W., Ivanov, J., Rakowski, H., Wigle, E. D., Linghorne, M., Ralph-Edwards, A. C., Williams, W. G., Schwartz, L., Guttman, A., & Woo, A. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.040 · Cited by 170

Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy.

Udelson, J. E., Bonow, R. O., O’Gara, P. T., Maron, B. J., van Lingen, A., Bacharach, S. L., & Epstein, S. E. (1989) · Circulation · doi:10.1161/01.cir.79.5.1052 · Cited by 167

Prediction of Thrombo-Embolic Risk in Patients with Hypertrophic Cardiomyopathy (HCM Risk-CVA)

Guttmann, O. P., Pavlou, M., O’Mahony, C., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., García‐Pavía, P., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.316 · Cited by 165

Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy

Fumagalli, C., Maurizi, N., Day, S. M., Ashley, E. A., Michels, M., Colan, S. D., Jacoby, D. L., Marchionni, N., Vincent-Tompkins, J., Ho, C. Y., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.4268 · Cited by 163

Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy

Thaman, R., Gimeno, J. R., Murphy, R. T., Kubo, T., Sachdev, B., Mogensen, J., Elliott, P. M., & McKenna, W. J. (2005) · Heart · doi:10.1136/hrt.2003.031161 · Cited by 161

Prevention of inappropriate therapy in implantable cardioverter-defibrillators

Theuns, D. A. M. J., Klootwijk, A., Goedhart, D. M., & Jordaens, L. J. L. M. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.09.039 · Cited by 161

A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy

O’Mahony, C., Tome, M., Lambiase, P. D., Pantazis, A. A., Dickie, S., McKenna, W. J., & Elliot, P. M. (2013) · Heart · doi:10.1136/heartjnl-2012-303271 · Cited by 159

Long-Term Outcomes of Combined Epicardial and Endocardial Ablation of Monomorphic Ventricular Tachycardia Related to Hypertrophic Cardiomyopathy

Dukkipati, S. R., d’Ávila, A., Soejima, K., Bala, R., Inada, K., Singh, S. M., Stevenson, W. G., Marchlinski, F. E., & Reddy, V. Y. (2011) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.110.957290 · Cited by 156

Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators

Lampert, R. J., Olshansky, B., Heidbüchel, H., Lawless, C. E., Saarel, E. V., Ackerman, M. J., Calkins, H. G., Estes, N. A. M., Link, M. S., Maron, B. J., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.027828 · Cited by 156

Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population

Swiryn, S., Orlov, M. V., Benditt, D. G., Dimarco, J., Lloyd‐Jones, D. M., Karst, E., Qu, F., Slawsky, M., Turkel, M., & Waldo, A. L. (2016) · Circulation · doi:10.1161/circulationaha.115.020252 · Cited by 154

Pregnancy related complications in women with hypertrophic cardiomyopathy

Thaman, R., Varnava, A. M., Hamid, M. S., Firoozi, S., Sachdev, B., Condon, M., Gimeno, J. R., Murphy, R. T., Elliott, P. M., & McKenna, W. J. (2003) · Heart · doi:10.1136/heart.89.7.752 · Cited by 150

Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience

FABER, L. (2004) · European Journal of Echocardiography · doi:10.1016/j.euje.2004.01.001 · Cited by 150

Progression of Myocardial Fibrosis Assessed With Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy

Todiere, G., Aquaro, G. D., Piaggi, P., Formisano, F., Barison, A., Masci, P. G., Strata, E., Bacigalupo, L., Marzilli, M., Pingitore, A., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.076 · Cited by 149

Cardiopulmonary Exercise Testing and Prognosis in Hypertrophic Cardiomyopathy

Coats, C. J., Rantell, K., Bartnik, A., Patel, A., Mist, B., McKenna, W. J., & Elliott, P. M. (2015) · Circulation: Heart Failure · doi:10.1161/circheartfailure.114.002248 · Cited by 148

Nonfamilial Hypertrophic Cardiomyopathy: Prevalence, Natural History, and Clinical Implications.

Ingles, J., Burns, C., Bagnall, R. D., Lam, L., Yeates, L., Sarina, T., Puranik, R., Briffa, T. G., Atherton, J. J., Driscoll, T., et al. (2017) · PubMed · doi:10.1161/circgenetics.116.001620 · Cited by 148

Exercise Echocardiography in Asymptomatic HCM

Desai, M. Y., Bhonsale, A., Patel, P., Naji, P., Smedira, N. G., Thamilarasan, M., Lytle, B. W., & Lever, H. M. (2013) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2013.08.010 · Cited by 146

Patient re-contact after revision of genomic test results: points to consider—a statement of the American College of Medical Genetics and Genomics (ACMG)

David, K. L., Best, R. G., Brenman, L. M., Bush, L. W., Deignan, J. L., Flannery, D. B., Hoffman, J. D., Holm, I. A., Miller, D. T., O'Leary, J. C., et al. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0391-z · Cited by 145

Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial

Axelsson, A., Iversen, K. K., Vejlstrup, N. G., Ho, C. Y., Norsk, J. B., Langhoff, L., Ahtarovski, K. A., Corell, P., Havndrup, O., Jensen, M. K., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70241-4 · Cited by 138

Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy

Ingles, J., Sarina, T., Yeates, L., Hunt, L., Macciocca, I., McCormack, L., Winship, I., McGaughran, J. M., Atherton, J. J., & Semsarian, C. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.44 · Cited by 137

Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center

Hodges, K., Rivas, C. A. G., Aguilera, J., Borden, R., Alashi, A., Blackstone, E. H., Desai, M. Y., & Smedira, N. G. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.11.148 · Cited by 137

Penetrance of Hypertrophic Cardiomyopathy in Children and Adolescents

Jensen, M. K., Havndrup, O., Christiansen, M., Andersen, P. S., Diness, B. R., Raja, A. A., Skovby, F., Køber, L., & Bundgaard, H. (2012) · Circulation · doi:10.1161/circulationaha.111.090514 · Cited by 136

Results of Ventricular Septal Myectomy and Hypertrophic Cardiomyopathy (from Nationwide Inpatient Sample [1998–2010])

Panaich, S., Badheka, A. O., Chothani, A., Mehta, K. D., Patel, N., Deshmukh, A. J., Singh, V., Savani, G. T., Arora, S., Patel, N., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.075 · Cited by 135

Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy

Yetman, A. T., Hamilton, R. M., Benson, L. N., & McCrindle, B. W. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00493-8 · Cited by 134

Sudden Death in Childhood Cardiomyopathy

Bharucha, T., Lee, K. J., Daubeney, P. E. F., Nugent, A. W., Turner, C., Sholler, G. F., Robertson, T., Justo, R. N., Ramsay, J., Carlin, J. B., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.552 · Cited by 133

Survival After Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy

Batzner, A., Pfeiffer, B., Neugebauer, A., Aicha, D., Blank, C., & Seggewiss, H. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.064 · Cited by 132

Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score–matched cohort

Nguyen, A. P., Schaff, H. V., Hang, D., Nishimura, R. A., Geske, J. B., Dearani, J. A., Lahr, B. D., & Ommen, S. R. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.08.062 · Cited by 128

Outcome of Mildly Symptomatic or Asymptomatic Obstructive Hypertrophic Cardiomyopathy

Sorajja, P., Nishimura, R. A., Gersh, B. J., Dearani, J. A., Hodge, D. O., Wiste, H. J., & Ommen, S. R. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.079 · Cited by 126

Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis

Norrish, G., Cantarutti, N., Pissaridou, E., Ridout, D. A., Limongelli, G., Elliot, P. M., & Kaski, J. P. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317702519 · Cited by 125

The emerging role of the cardiac genetic counselor

Ingles, J., Yeates, L., & Semsarian, C. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.07.017 · Cited by 123

Pregnancy in women with hypertrophic cardiomyopathy: data from the European Society of Cardiology initiated Registry of Pregnancy and Cardiac disease (ROPAC)

Goland, S., van Hagen, I. M., Elbaz‐Greener, G., Elkayam, U., Shotan, A., Merz, W. M., Enar, S. Ç., Гайсин, И. Р., Pieper, P. G., Johnson, M. R., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx189 · Cited by 123

Establishment of Specialized Clinical Cardiovascular Genetics Programs: Recognizing the Need and Meeting Standards: A Scientific Statement From the American Heart Association

Ahmad, F., McNally, E. M., Ackerman, M. J., Baty, L., Day, S. M., Kullo, I. J., Madueme, P. C., Maron, M. S., Martinez, M. W., Salberg, L. R., et al. (2019) · Circulation Genomic and Precision Medicine · doi:10.1161/hcg.0000000000000054 · Cited by 123

Echocardiography in Hypertrophic Cardiomyopathy

Afonso, L., Bernal, J., Bax, J. J., & Abraham, T. P. (2008) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2008.09.002 · Cited by 122

Toronto Hypertrophic Cardiomyopathy Genotype Score for Prediction of a Positive Genotype in Hypertrophic Cardiomyopathy

Gruner, C., Ivanov, J., Care, M. E., Williams, L. K., Moravsky, G., Yang, H., Laczay, B., Siminovitch, K. A., Woo, A., & Rakowski, H. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.112.963363 · Cited by 122

Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis

Providencia, R., Elliott, P., Patel, K., McCready, J., Babu, G., Srinivasan, N., Bronis, K., Papageorgiou, N., Chow, A., Rowland, E., et al. (2016) · Heart · doi:10.1136/heartjnl-2016-309406 · Cited by 122

Radiofrequency catheter ablation of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: safety and feasibility

Santangeli, P., Biase, L. D., Lakkireddy, D., Burkhardt, J. D., Pillarisetti, J., Michowitz, Y., Sánchez, J., Horton, R., Mohanty, P. K., Gallinghouse, G. J., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.05.022 · Cited by 121

Long-term propranolol therapy in muscular subaortic stenosis.

Adelman, A. G., Shah, P. M., Gramiak, R., & Wigle, E. D. (1970) · Heart · doi:10.1136/hrt.32.6.804 · Cited by 121

Longevity of Sprint Fidelis Implantable Cardioverter-Defibrillator Leads and Risk Factors for Failure

Hauser, R. G., Maisel, W. H., Friedman, P. A., Kallinen, L. M., Mugglin, A. S., Kumar, K., Hodge, D. O., Morrison, T. B., & Hayes, D. L. (2011) · Circulation · doi:10.1161/circulationaha.110.975219 · Cited by 121

Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy

Raja, A. A., Farhad, H., Valente, A. M., Couce, J.-P., Jefferies, J. L., Bundgaard, H., Zahka, K. G., Lever, H. M., Murphy, A. M., Ashley, E. A., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032966 · Cited by 115

A double-blind, placebo-controlled crossover trial of nadolol and verapamil in mild and moderately symptomatic hypertrophic cardiomyopathy

Gilligan, D. M., Chan, W., Joshi, J., Clarke, P., FLETCHER, A. E., Krikler, S. J., & Oakley, C. M. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90386-f · Cited by 112

Advanced Heart Failure With Preserved Systolic Function in Nonobstructive Hypertrophic Cardiomyopathy

Rowin, E. J., Maron, B. J., Kiernan, M. S., Casey, S. A., Feldman, D. S., Hryniewicz, K. M., Chan, R. H. M., Harris, K. M., Udelson, J. E., DeNofrio, D. D., et al. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001435 · Cited by 111

Relation of electrocardiographic abnormalities to evolving left ventricular hypertrophy in hypertrophic cardiomyopathy during childhood

Panza, J. A., & Maron, B. J. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90187-2 · Cited by 110

Catheter Ablation of Atrial Fibrillation in Hypertrophic Cardiomyopathy

Santangeli, P., Biase, L. D., Themistoclakis, S., Raviele, A., Schweikert, R. A., Lakkireddy, D., Mohanty, P. K., Bai, R., Mohanty, S., Pump, A., et al. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000339 · Cited by 110

Role of ventricular assist therapy for patients with heart failure and restrictive physiology: Improving outcomes for a lethal disease

Grupper, A., Park, S. J., Pereira, N. L., Schettle, S. D., Gerber, Y., Topilsky, Y., Edwards, B. S., Daly, R. C., Stulak, J. M., Joyce, L. D., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.03.012 · Cited by 109

Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts

Lambiase, P. D., Gold, M. R., Hood, M., Boersma, L. V. A., Theuns, D. A. M. J., Burke, M. C., Weiss, R., Russo, A. M., Kääb, S., & Knight, B. P. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.01.001 · Cited by 108

Conduction Abnormalities and Long-Term Mortality Following Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy

Cui, H. Z., Schaff, H. V., Nishimura, R. A., Geske, J. B., Dearani, J. A., Lahr, B. D., & Ommen, S. R. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.05.053 · Cited by 108

Hypertrophic subaortic stenosis

Stenson, R. E., Flamm, M. D., Harrison, D. C., & Hancock, E. W. (1973) · The American Journal of Cardiology · doi:10.1016/0002-9149(73)90012-x · Cited by 107

Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: Patient outcomes, rate of appropriate and inappropriate interventions, and complications

Vriesendorp, P. A., Schinkel, A. F. L., Cleemput, J. V., Willems, R., Jordaens, L. J. L. M., Theuns, D. A. M. J., van Slegtenhorst, M. A., de Ravel, T. J. L., ten Cate, F. J., & Michels, M. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.06.009 · Cited by 105

Benefits of intraoperative echocardiography in the surgical management of hypertrophic cardiomyopathy

Marwick, T. H., Stewart, W. J., Lever, H. M., Lytle, B. W., Rosenkranz, E. R., Duffy, C. I., & Salcedo, E. E. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90359-u · Cited by 105

Provocation of latent left ventricular outflow tract gradients with amyl nitrite and exercise in hypertrophic cardiomyopathy

Marwick, T. H., Nakatani, S., Haluska, B. A., Thomas, J. D., & Lever, H. M. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80416-0 · Cited by 103

Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy

Wang, W., Lian, Z., Rowin, E. J., Maron, B. J., Maron, M. S., & Link, M. S. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004604 · Cited by 103

Determining pathogenicity of genetic variants in hypertrophic cardiomyopathy: importance of periodic reassessment

Jipin Das, K., Ingles, J., Bagnall, R. D., & Semsarian, C. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.138 · Cited by 103

Role of Family History of Sudden Death in Risk Stratification and Prevention of Sudden Death With Implantable Defibrillators in Hypertrophic Cardiomyopathy

Bos, J. M., Maron, B. J., Ackerman, M. J., Haas, T. S., Sorajja, P., Nishimura, R. A., Gersh, B. J., & Ommen, S. R. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.06.077 · Cited by 102

Standards defining a ‘Heart Valve Centre’: ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery Viewpoint

Chambers, J. B., Prendergast, B., Iung, B., Rosenhek, R., Zamorano, J. L., Piérard, L., Modine, T., Falk, V., Kappetein, A. P., Pîbarot, P., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx370 · Cited by 101

Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines?

Lafrenière‐Roula, M., Bolkier, Y., Zahavich, L. A., Mathew, J., George, K., Wilson, J., Stephenson, E. A., Benson, L. N., Manlhiot, C., & Mital, S. R. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz396 · Cited by 101

Outcomes of Restrictive and Hypertrophic Cardiomyopathies After LVAD: An INTERMACS Analysis

Patel, S. R., Saeed, O., Naftel, D. C., Myers, S. L., Kirklin, J. K., Jorde, U. P., & Goldstein, D. J. (2017) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2017.09.011 · Cited by 100

Discrepant Measurements of Maximal Left Ventricular Wall Thickness Between Cardiac Magnetic Resonance Imaging and Echocardiography in Patients With Hypertrophic Cardiomyopathy

Hindieh, W., Weissler‐Snir, A., Hammer, H., Adler, A., Rakowski, H., & Chan, R. H. M. (2017) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.117.006309 · Cited by 99

Communicating new knowledge on previously reported genetic variants

Aronson, S., Clark, E. H., Varugheese, M., Baxter, S. M., Babb, L. J., & Rehm, H. L. (2012) · Genetics in Medicine · doi:10.1038/gim.2012.19 · Cited by 98

Management Implications of Massive Left Ventricular Hypertrophy in Hypertrophic Cardiomyopathy Significantly Underestimated by Echocardiography but Identified by Cardiovascular Magnetic Resonance

Maron, M. S., Lesser, J. R., & Maron, B. J. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.01.367 · Cited by 97

Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives

Norrish, G., Jager, J., Field, E., Quinn, E., Fell, H., Lord, E., Cicerchia, M., Ochoa, J. P., Cervi, E., Elliot, P. M., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.038846 · Cited by 94

Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic Cardiomyopathy

Pasqualucci, D., Fornaro, A., Castelli, G., Rossi, A., Arretini, A., Chiriatti, C., Targetti, M., Girolami, F., Corda, M., Orrù, P., et al. (2015) · Circulation: Heart Failure · doi:10.1161/circheartfailure.114.001843 · Cited by 93

Vigorous exercise in patients with hypertrophic cardiomyopathy

Dejgaard, L. A., Haland, T. F., Lie, O. H., Ribe, M. P., Bjune, T., Leren, I. S., Berge, K. E., Edvardsen, T., & Haugaa, K. H. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.07.015 · Cited by 88

Targeting Percutaneous Transluminal Septal Ablation for Hypertrophic Obstructive Cardiomyopathy by Intraprocedural Echocardiographic Monitoring

Faber, L., Ziemssen, P., & Seggewiß, H. (2000) · Journal of the American Society of Echocardiography · doi:10.1067/mje.2000.108250 · Cited by 87

Pulmonary hypertension is associated with worse survival in hypertrophic cardiomyopathy

Ong, K. C., Geske, J. B., Hebl, V. B., Nishimura, R. A., Schaff, H. V., Ackerman, M. J., Klarich, K. W., Siontis, K. C., Coutinho, T. A., Dearani, J. A., et al. (2016) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jew024 · Cited by 87

Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery

Qin, J. X., Shiiota, T., & Lever, H. M. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00561-5 · Cited by 87

Standing and Exercise Doppler Echocardiography in Obstructive Hypertrophic Cardiomyopathy: The Range of Gradients with Upright Activity

Joshi, S. A., Patel, U. K., Yao, S., Castenada, V., Isambert, A., Winson, G., Chaudhry, F. A., & Sherrid, M. V. (2010) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2010.10.006 · Cited by 86

Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy

Mathew, J., Zahavich, L. A., Lafrenière‐Roula, M., Wilson, J., George, K., Benson, L. N., Bowdin, S. C., & Mital, S. R. (2017) · Clinical Genetics · doi:10.1111/cge.13157 · Cited by 86

Outcomes of catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis

Zhao, D.-S., Shen, Y., Zhang, Q., Lin, G., Lu, Y.-H., Chen, B.-T., Shi, L.-S., Huang, J.-F., & Lu, H.-H. (2015) · EP Europace · doi:10.1093/europace/euv339 · Cited by 85

Safety of Outpatient Initiation of Disopyramide for Obstructive Hypertrophic Cardiomyopathy Patients

Adler, A., Fourey, D., Weissler‐Snir, A., Hindieh, W., Chan, R. H. M., Gollob, M. H., & Rakowski, H. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005152 · Cited by 84

Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy

Ciampi, Q., Betocchi, S., Lombardi, R., Manganelli, F., Storto, G., Losi, M. A., Pezzella, E., Finizio, F., Cuocolo, A., & Massimo Chiariello, A. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01950-2 · Cited by 83

Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy

Christiaans, I., Birnie, E., Bonsel, G. J., Mannens, M. M. A. M., Michels, M., Majoor-Krakauer, D., Dooijes, D., van Tintelen, J. P., van den Berg, M. P., Volders, P. G. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr092 · Cited by 83

Concomitant Septal Myectomy at the Time of Aortic Valve Replacement for Severe Aortic Stenosis

Kayalar, N., Schaff, H. V., Daly, R. C., Dearani, J. A., & Park, S. J. (2010) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2009.10.065 · Cited by 81

Variability of Left Ventricular Outflow Tract Gradient During Cardiac Catheterization in Patients With Hypertrophic Cardiomyopathy

Geske, J. B., Sorajja, P., Ommen, S. R., & Nishimura, R. A. (2011) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2011.02.014 · Cited by 81

Cardiovascular collapse after verapamil in supraventricular tachycardia.

Kirk, R., Gibbs, J. L., Thomas, R. D., Radley-Smith, R., & Qureshi, S. (1987) · Archives of Disease in Childhood · doi:10.1136/adc.62.12.1265 · Cited by 81

Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy

Chen, M. S., McCarthy, P. M., Lever, H. M., Smedira, N. G., & Lytle, B. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.10.025 · Cited by 80

Planned vaginal delivery and cardiovascular morbidity in pregnant women with heart disease

Easter, S. R., Rouse, C. E., Duarte, V. E., Hynes, J. S., Singh, M. N., Landzberg, M. J., Valente, A. M., & Economy, K. E. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.07.019 · Cited by 80

Competitive Sport Participation Among Athletes With Heart Disease

Baggish, A. L., Ackerman, M. J., & Lampert, R. J. (2017) · Circulation · doi:10.1161/circulationaha.117.029639 · Cited by 79

Outcomes of Contemporary Family Screening in Hypertrophic Cardiomyopathy

van Velzen, H. G., Schinkel, A. F. L., Baart, S. J., Oldenburg, R. A., Frohn-Mulder, I. M. E., van Slegtenhorst, M. A., & Michels, M. (2018) · Circulation: Genomic and Precision Medicine · doi:10.1161/circgen.117.001896 · Cited by 79

Hypertrophic remodelling in cardiac regulatory myosin light chain ( MYL2 ) founder mutation carriers

Claes, G. R. F., van Tienen, F. H. J., Lindsey, P. J., Krapels, I. P. C., den Enden, A. T. J. M. H.-V., Hoos, M. B., Barrois, Y. E. G., Janssen, J. W. H., Paulussen, A. D. C., Sels, J.-W. E. M., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv522 · Cited by 78

Global burden of atrial fibrillation/atrial flutter and its attributable risk factors from 1990 to 2021

Cheng, S., He, J., Han, Y., Han, S., Li, P., Liao, H., & Guo, J. (2024) · EP Europace · doi:10.1093/europace/euae195 · Cited by 285

Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy

Zhou, M., Ta, S., Hahn, R. T., Hsi, D. H., Leon, M. B., Hu, R., Zhang, J., Zuo, L., Li, J., Wang, J., et al. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2022.0259 · Cited by 107

Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies

Aquaro, G. D., Gori, C. D., Faggioni, L., Parisella, M. L., Cioni, D., Lencioni, R. A., & Neri, E. (2023) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suad015 · Cited by 106

Arrhythmias as Presentation of Genetic Cardiomyopathy

Laws, J. L., Lancaster, M. C., Shoemaker, M. B., Stevenson, W. G., Hung, R. R., Wells, Q. S., Brinkley, D. M., Hughes, S. G., Anderson, K. C., Roden, D. M., et al. (2022) · Circulation Research · doi:10.1161/circresaha.122.319835 · Cited by 92

Friedreich Ataxia: Multidisciplinary Clinical Care

Lynch, D. R., Schadt, K. A., Kichula, E. A., McCormack, S. E., & Lin, K. Y. (2021) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s292945 · Cited by 73

Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy

Nauffal, V., Marstrand, P., Han, L., Parikh, V. N., Helms, A. S., Ingles, J., Jacoby, D. L., Lakdawala, N. K., Kapur, S., Michels, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab598 · Cited by 69

External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy

Norrish, G., Chen, Q., Field, E., Cervi, E., Khraiche, D., Klaassen, S., Ojala, T. H., Sinagra, G., Yamazawa, H., Marrone, C., et al. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab181 · Cited by 69

Ramadan fasting: recommendations for patients with cardiovascular disease

Akhtar, A. M., Ghouri, N., Chahal, C. A. A., Patel, R. S., Ricci, F., Sattar, N. A., Waqar, S., & Khanji, M. Y. (2021) · Heart · doi:10.1136/heartjnl-2021-319273 · Cited by 66

Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real‐World Data

Buckley, B. J. R., Harrison, S. L., Gupta, D., Fazio‐Eynullayeva, E., Underhill, P., & Lip, G. Y. H. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021970 · Cited by 64

Left Ventricular Hypertrophy: Etiology-Based Therapeutic Options

Sayın, B. Y., & Oto, A. (2022) · Cardiology and Therapy · doi:10.1007/s40119-022-00260-y · Cited by 60

Metabolic characterization of hypertrophic cardiomyopathy in human heart

Wang, W., Wang, J., Yao, K., Wang, S., Nie, M., Zhao, Y., Wang, B., Pang, H., Xu, J., Wu, G., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00057-1 · Cited by 58

Genetic Testing in Patients with Hypertrophic Cardiomyopathy

Bonaventura, J., Polaková, E., Vejtasová, V., & Veselka, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910401 · Cited by 55

Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy

Norrish, G., Cleary, A., Field, E., Cervi, E., Boleti, O., Ziółkowska, L., Olivotto, I., Khraiche, D., Limongelli, G., Anastasakis, A., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.03.347 · Cited by 52

Transcatheter Myotomy to Relieve Left Ventricular Outflow Tract Obstruction: The Septal Scoring Along the Midline Endocardium Procedure in Animals

Khan, J. M., Bruce, C. G., Greenbaum, A. B., Babaliaros, V. C., Jaimes, A. E., Schenke, W. H., Ramasawmy, R., Seemann, F., Herzka, D. A., Rogers, T., et al. (2022) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.121.011686 · Cited by 51

Thin filament cardiomyopathies: A review of genetics, disease mechanisms, and emerging therapeutics

Keyt, L. K., Duran, J. M., Bui, Q. M., Chen, C., Miyamoto, M. I., Enciso, J. S., Tardiff, J. C., & ADLER, E. D. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.972301 · Cited by 50

Hospital Procedural Volume and Clinical Outcomes Following Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy

Altibi, A. M. A., Ghanem, F. H., Zhao, Y., Elman, M., Cigarroa, J. E., Nazer, B., Song, H. K., & Masri, A. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.028693 · Cited by 50

Cardiac Myosin Inhibitors as a Novel Treatment Option for Obstructive Hypertrophic Cardiomyopathy: Addressing the Core of the Matter

Masri, A., & Olivotto, I. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024656 · Cited by 48

Randomized Controlled Trial of Moderate‐ and High‐Intensity Exercise Training in Patients With Hypertrophic Cardiomyopathy: Effects on Fitness and Cardiovascular Response to Exercise

MacNamara, J. P., Dias, K. A., Hearon, C. M., Ivey, E., Delgado, V. A., Saland, S., Samels, M. R., Hieda, M., Turer, A. T., Link, M. S., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.031399 · Cited by 46

Apical hypertrophic cardiomyopathy: pathophysiology, diagnosis and management

Li, J., Fang, J., Liu, Y., & Wei, X. (2023) · Clinical Research in Cardiology · doi:10.1007/s00392-023-02328-8 · Cited by 44

Diagnosis and Management of Patients with Left Ventricular Hypertrophy: Role of Multimodality Cardiac Imaging. A Scientific Statement of the Heart Failure Association of the European Society of Cardiology

Moura, B., Aimo, A., Al‐Mohammad, A., Keramida, K., Gal, T. B., Dorbala, S., Todiere, G., Cameli, M., Barison, A., Bayés‐Genís, A., et al. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.2997 · Cited by 44

Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells

Li, J., Feng, X., & Wei, X. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02905-0 · Cited by 42

Prevalence, incidence and mortality of hypertrophic cardiomyopathy based on a population cohort of 21.9 million in China

Bai, Y., Zheng, J.-P., Lu, F., Zhang, X.-L., Sun, C.-P., Guo, W.-H., Zou, Y.-X., Lip, G. Y. H., & Shi, X.-B. (2022) · Scientific Reports · doi:10.1038/s41598-022-20042-9 · Cited by 41

Implantable defibrillators in primary prevention of genetic arrhythmias. A shocking choice?

Corrado, D., Link, M. S., & Schwartz, P. J. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac298 · Cited by 41

Molecular Diagnosis of Hypertrophic Cardiomyopathy (HCM): In the Heart of Cardiac Disease

Melas, M., Beltsios, E. T., Adamou, A., Koumarelas, K. E., & McBride, K. L. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010225 · Cited by 37

Young athlete’s growing heart: sex differences in cardiac adaptation to exercise training during adolescence

Forså, M. I., Bjerring, A. W., Haugaa, K. H., Smedsrud, M. K., Sarvari, S. I., Landgraff, H. W., Hallén, J., & Edvardsen, T. (2023) · Open Heart · doi:10.1136/openhrt-2022-002155 · Cited by 36

Is There a Sex Difference in the Prognosis of Hypertrophic Cardiomyopathy? A Systematic Review and Meta‐Analysis

Zhao, H., Tan, Z., Liu, M., Yu, P., Ma, J., Li, X., Wang, J., Zhao, Y., Zhu, W., & Liu, X. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.026270 · Cited by 35

Eighteen‐Month Real‐World Experience Using Mavacamten for Treatment of Obstructive Hypertrophic Cardiomyopathy in a Racially Diverse Population

Ramonfaur, D., Gasperetti, A., Blake, V., Rivers, B. J., Kassamali, A. A., Kasper, E. K., Barouch, L. A., Wu, K. C., Madrazo, J., & Carrick, R. T. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.034069 · Cited by 34

Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Rationale for Clinically Guided Dose Titration to Optimize Individual Response

OWENS, A. T., Desai, M. Y., Wheeler, M. T., Rodonski, A., Merali, S. J., Sehnert, A. J., & Saberi, S. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.033767 · Cited by 31

Emerging Medical Treatment for Hypertrophic Cardiomyopathy

Argirò, A., Zampieri, M., Berteotti, M., Marchi, A. G., Tassetti, L., Zocchi, C., Iannone, L., Bacchi, B., Cappelli, F., Stefàno, P., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10050951 · Cited by 31

Role of Genetics in Diagnosis and Management of Hypertrophic Cardiomyopathy: A Glimpse into the Future

Abbas, M. T., Ali, N. B., Farina, J., Mahmoud, A., Pereyra, M., Scalia, I. G., Kamel, M., Barry, T., Lester, S. J., Cannan, C. R., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12030682 · Cited by 30

Advancing Sports Cardiology: Integrating Artificial Intelligence with Wearable Devices for Cardiovascular Health Management

Zheng, X. H., Liu, Z., Liu, J., Hu, C., Du, Y., Li, J., Pan, Z., & Ding, K. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c22895 · Cited by 30

Real-World Candidacy to Mavacamten in a Contemporary Hypertrophic Obstructive Cardiomyopathy Population

Bertero, E., Chiti, C., Schiavo, M. A., Tini, G., Costa, P., Todiere, G., Mabritto, B. M. T., Dei, L., Giannattasio, A., Mariani, D., et al. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.3120 · Cited by 30

Aficamten and Cardiopulmonary Exercise Test Performance

Lee, M. M. Y., Masri, A., Nassif, M. E., Villa, R. B., Abraham, T. P., Claggett, B. L., COATS, C. J., Gimeno, J. R., Kulac, I. J., Landsteiner, I., et al. (2024) · JAMA Cardiology · doi:10.1001/jamacardio.2024.2781 · Cited by 29

Pediatric Hypertrophic Cardiomyopathy: Exploring the Genotype‐Phenotype Association

Nguyen, M. B., Mital, S. R., Mertens, L., Jeewa, A., Friedberg, M. K., Aguet, J., Adler, A., Lam, C. Z., Dragulescu, A., Rakowski, H., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024220 · Cited by 29

Familial Hypertrophic Cardiomyopathy: Diagnosis and Management

Litt, M. J., Ali, A., & Reza, N. (2023) · Vascular Health and Risk Management · doi:10.2147/vhrm.s365001 · Cited by 29

Machine learning algorithms to automate differentiating cardiac amyloidosis from hypertrophic cardiomyopathy

Wu, Z.-W., Zheng, J.-L., Kuang, L., & Yan, H. (2022) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-022-02738-1 · Cited by 28

Multi-Omics Profiling of Hypertrophic Cardiomyopathy Reveals Altered Mechanisms in Mitochondrial Dynamics and Excitation–Contraction Coupling

Moore, J., Ewoldt, J. K., Venturini, G., Pereira, A. C., Padilha, K., Lawton, M. L., Lin, W., Goel, R. K., Luptak, I., Perissi, V., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054724 · Cited by 28

Echocardiography-based machine learning algorithm for distinguishing ischemic cardiomyopathy from dilated cardiomyopathy

Zhou, M. L., Deng, Y., Liu, Y., Su, X., & Zeng, X. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03520-4 · Cited by 28

Machine learning techniques for arrhythmic risk stratification: a review of the literature

Chung, C. T., Bazoukis, G., Lee, S., Liu, Y., Liu, T., Letsas, Κ. P., Armoundas, A. A., & Tse, G. (2022) · International Journal of Arrhythmia · doi:10.1186/s42444-022-00062-2 · Cited by 26

Disease Expression and Outcomes in Black and White Adults With Hypertrophic Cardiomyopathy

Arabadjian, M. E., Yu, G., Sherrid, M. V., & Dickson, V. V. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019978 · Cited by 26

Prediction of Genotype Positivity in Patients With Hypertrophic Cardiomyopathy Using Machine Learning

Liang, L. W., Fifer, M. A., Hasegawa, K., Maurer, M. S., Reilly, M. P., & Shimada, Y. J. (2021) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.120.003259 · Cited by 25

Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy

Maurizi, N., Chiriatti, C., Fumagalli, C., Targetti, M., Passantino, S., Antiochos, P., Skalidis, I., Chiti, C., Biagioni, G., Tomberli, A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072725 · Cited by 25

Model for classification of heart failure severity in patients with hypertrophic cardiomyopathy using a deep neural network algorithm with a 12-lead electrocardiogram

Togo, S., Sugiura, Y., Suzuki, S., Ohno, K., Akita, K., Suwa, K., Shibata, S., Kimura, M., & Maekawa, Y. (2023) · Open Heart · doi:10.1136/openhrt-2023-002414 · Cited by 24

Evaluation of the 2021 ESC Recommendations for Family Screening in Hereditary Transthyretin Cardiac Amyloidosis

Muller, S. A., Aventín, B. P., Biagioni, G., Tini, G., Saturi, G., Kronberger, C., Achten, A., Dobner, S., Rijdt, W. P. T., Gasperetti, A., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3339 · Cited by 24

Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy

Norrish, G., Ding, T., Field, E., Cervi, E., Ziółkowska, L., Olivotto, I., Khraiche, D., Limongelli, G., Anastasakis, A., Weintraub, R. G., et al. (2022) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.121.010075 · Cited by 24

Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective

Gragnano, F., Pelliccia, F., Guarnaccia, N., Niccoli, G., Rosa, S. D., Piccolo, R., Moscarella, E., Fabris, E., Montone, R. A., Cesaro, A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082810 · Cited by 24

Identification of high-risk imaging features in hypertrophic cardiomyopathy using electrocardiography: A deep-learning approach

Carrick, R. T., Ahamed, H., Sung, E., Maron, M. S., Madias, C. A., Avula, V. R., Studley, R., Chen, B., Bokhari, N. A., Quintana, E., et al. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.01.031 · Cited by 24

Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere

Norrish, G., Field, E., & Kaski, J. P. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.708679 · Cited by 23

The Genetic Architecture of Hypertrophic Cardiomyopathy in Hungary: Analysis of 242 Patients with a Panel of 98 Genes

Sepp, R., Haţegan, L., Csányi, B., Borbás, J., Tringer, A., Pálinkás, E. D., Nagy, V., Takács, H., Latinovics, D., Nyolczas, N., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12051132 · Cited by 23

Tandem deep learning and logistic regression models to optimize hypertrophic cardiomyopathy detection in routine clinical practice

Maanja, M., Noseworthy, P. A., Geske, J. B., Ackerman, M. J., Arruda-Olson, A. M., Ommen, S. R., Attia, Z. I., Friedman, P. A., & Siontis, K. C. (2022) · Cardiovascular Digital Health Journal · doi:10.1016/j.cvdhj.2022.10.002 · Cited by 22

Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy and the impact of mavacamten

Mathai, S., & Williams, L. K. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221136074 · Cited by 22

Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry

Alaiwi, S. A., Roston, T. M., Marstrand, P., Claggett, B. L., Parikh, V. N., Helms, A. S., Ingles, J., Lampert, R. J., Lakdawala, N. K., Michels, M., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.062517 · Cited by 22

Predictive value of left atrial strain analysis in adverse clinical events in patients with hypertrophic cardiomyopathy: a CMR study

Tian, D., Zhang, J., He, Y., Xiong, Z., Zhao, M., Hu, S., Song, Q., & Li, Z. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03069-2 · Cited by 21

Deficiency of Transcription Factor Sp1 Contributes to Hypertrophic Cardiomyopathy

Zhang, F., Zhou, H., Xue, J., Zhang, Y., Zhou, L., Leng, J., Fang, G., Liu, Y., Wang, Y., Liu, H., et al. (2024) · Circulation Research · doi:10.1161/circresaha.123.323272 · Cited by 21

Aficamten: A Breakthrough Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy

Sebastian, S. A., Padda, I., Lehr, E. J., & Johal, G. (2023) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-023-00599-0 · Cited by 20

Effect of Mavacamten in Women Compared With Men With Obstructive Hypertrophic Cardiomyopathy: Insights From EXPLORER-HCM

Cresci, S., Bach, R. G., Saberi, S., OWENS, A. T., Spertus, J. A., Hegde, S. M., Lakdawala, N. K., Nilles, E. K., WOJDYLA, D. M., Sehnert, A. J., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.065600 · Cited by 20

Disparities in heart and lung transplantation

Tsuang, W. M., Khedraki, R., & Hsich, E. (2021) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000916 · Cited by 20

Deep Neural Network for Cardiac Magnetic Resonance Image Segmentation

Chen, D. J., Bhopalwala, H. M., Dewaswala, N., Arunachalam, S. P., Enayati, M., Farahani, N. Z., Pasupathy, K. S., Lokineni, S., Bos, J. M., Noseworthy, P. A., et al. (2022) · Journal of Imaging · doi:10.3390/jimaging8050149 · Cited by 19

Remodelling of potassium currents underlies arrhythmic action potential prolongation under beta-adrenergic stimulation in hypertrophic cardiomyopathy

Doste, R., Coppini, R., & Bueno‐Orovio, A. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.08.361 · Cited by 19

Artificial intelligence in the pediatric echocardiography laboratory: Automation, physiology, and outcomes

Nguyen, M. B., Villemain, O., Friedberg, M. K., Løvstakken, L., Rusin, C. G., & Mertens, L. (2022) · Frontiers in Radiology · doi:10.3389/fradi.2022.881777 · Cited by 19

Role of Biomarkers of Myocardial Injury to Predict Adverse Outcomes in Hypertrophic Cardiomyopathy

Zhang, Y., Liu, M., Zhang, C., Zou, Y., Kang, L., & Song, L. (2024) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.123.010243 · Cited by 19

Mavacamten for hypertrophic cardiomyopathy: effectiveness and value

Beinfeld, M. T., Wasfy, J. H., Walton, S. M., Sarker, J., Nhan, E., Rind, D. M., & Pearson, S. D. (2022) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2022.28.3.369 · Cited by 19

Performance of heart rate adjusted heart rate variability for risk stratification of sudden cardiac death

Yan, S.-P., Song, X., Wei, L. B., Gong, Y., Hu, H.-Y., & Li, Y. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03184-0 · Cited by 18

Developing a genetic testing panel for evaluation of morbidities in kidney transplant recipients

Ma, B. M., Elefant, N., Tedesco, M., Bogyo, K., Vena, N., Murthy, S. B. K., Bheda, S., Yang, S. Y.-R., Tomar, N., Zhang, J. Y., et al. (2024) · Kidney International · doi:10.1016/j.kint.2024.02.021 · Cited by 18

The clinical utility of pediatric cardiomyopathy genetic testing: From diagnosis to a precision medicine-based approach to care

Parker, L. E., & Landstrom, A. P. (2021) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2021.101413 · Cited by 18

Current and Potential Applications of Wearables in Sports Cardiology

Rao, P., Seshadri, D. R., & Hsu, J. J. (2021) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-021-00942-1 · Cited by 18

Augmented risk of ischemic stroke in hypertrophic cardiomyopathy patients without documented atrial fibrillation

Choi, Y., Kim, B., Rhee, T., Lee, H., Lee, H., Park, J., Lee, S., Han, K., Kim, Y.-J., & Kim, H. (2022) · Scientific Reports · doi:10.1038/s41598-022-19895-x · Cited by 18

Founder mutation in myosin-binding protein C with an early onset and a high penetrance in males

Méndez, I., Fernández, A. I., Espinosa, M. Á., Cuenca, S., Lorca, R., Rodríguez, J. F., Tamargo, M., Garcia-Montero, M., Gómez, C., Vilches, S., et al. (2021) · Open Heart · doi:10.1136/openhrt-2021-001789 · Cited by 17

Cardiopulmonary Fitness and Personalized Exercise Prescription in Patients With Hypertrophic Cardiomyopathy

Cavigli, L., Ragazzoni, G. L., Vannuccini, F., Targetti, M., Mandoli, G. E., Senesi, G., Pastore, M. C., Focardi, M., Cameli, M., Valente, S., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.036593 · Cited by 17

Advances in Multimodality Cardiovascular Imaging in the Diagnosis of Heart Failure With Preserved Ejection Fraction

Torto, A. D., Guaricci, A. I., Pomarico, F., Guglielmo, M., Fusini, L., Monitillo, F., Santoro, D., Vannini, M., Rossi, A., Muscogiuri, G., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.758975 · Cited by 16

The Additional Value of T1 Mapping in Cardiac Disease: State of the Art

Ascione, R., Giorgi, M. D., Dell’Aversana, S., Costanzo, G., Nappi, C., Imbriaco, M., & Ponsiglione, A. (2023) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-023-09588-y · Cited by 16

Low T3 syndrome predicts more adverse events in patients with hypertrophic cardiomyopathy

He, C., Zhu, C., Fan, H., Qian, Y., Zhai, C., & Hu, H. (2023) · Clinical Cardiology · doi:10.1002/clc.24156 · Cited by 15

Healthcare resource utilization and cost of obstructive hypertrophic cardiomyopathy in a US population

Butzner, M., Maron, M. S., Sarocco, P., Teng, C., Stanek, E. J., Tan, H., & Robertson, L. (2022) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2022.100089 · Cited by 15

Future Role of New Negative Inotropic Agents in the Era of Established Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy

Maron, B. J., Maron, M. S., Sherrid, M. V., & Rowin, E. J. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024566 · Cited by 15

Diagnosis and Clinical Implication of Left Ventricular Aneurysm in Hypertrophic Cardiomyopathy

Perillo, E. F., Canciello, G., Borrelli, F., Todde, G., Imbriaco, M., Ordine, L., Napoli, S., Lombardi, R., Esposito, G., & Losi, M. A. (2023) · Diagnostics · doi:10.3390/diagnostics13111848 · Cited by 14

2023 Expert Consensus of the Taiwan Society of Cardiology on the Diagnosis and Treatment of Cardiac Amyloidosis.

Wang, C., Chang, W., Lin, Y., Tzeng, B., Chao, T., Hung, C., Wu, Y., Tsai, C., Lin, W.-W., Chang, K., et al. (2023) · PubMed Central · doi:10.6515/acs.202307_39(4).20230610a · Cited by 14

Midterm Outcomes of Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Cardiomyopathy: A Single‐Center, Observational Study

Xie, X., Chen, S., Cui, Y., Zhou, Z., Lü, J., Du, Z. J., Ding, J., Xing, K., Zhang, Y., Zhou, Y., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.034080 · Cited by 14

Review of Contemporary Invasive Treatment Approaches and Critical Appraisal of Guidelines on Hypertrophic Obstructive Cardiomyopathy: State-of-the-Art Review

Lebowitz, S., Kowalewski, M., Raffa, G. M., Chu, D., Greco, M., Gandolfo, C. M., Mignosa, C., Lorusso, R., Suwalski, P., & Pilato, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123405 · Cited by 14

Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy and Cardiac Amyloidosis: From Clinical Management to Catheter Ablation Indication

Mistrulli, R., Ferrera, A., Muthukkattil, M. L., Battistoni, A., Gallo, G., Barbato, E., Spera, F. R., & Magrì, D. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020501 · Cited by 14

Age-Related Survival After Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy

Batzner, A., Aicha, D., Pfeiffer, B., Neugebauer, A., & Seggewiß, H. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13750 · Cited by 14

Cardiac device implantation and device usage in Fabry and hypertrophic cardiomyopathy

Vijapurapu, R., Bradlow, W. M., Leyva, F., Moon, J., Zegard, A., Lewis, N. T., Kotecha, D., Jovanović, A., Hughes, D. A., Woolfson, P. I., et al. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-02133-4 · Cited by 14

Clonal Haematopoiesis is Associated with Major Adverse Cardiovascular Events in Patients with Hypertrophic Cardiomyopathy

Scolari, F. L., Brahmbhatt, D. H., Abelson, S., Lee, D. Z. J., Kim, R. H., Pedarzadeh, A., Sakhnini, A., Adler, A., Chan, R. H. M., Dick, J. E., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3408 · Cited by 13

Cardiopulmonary Exercise Testing in Pediatric Patients With Hypertrophic Cardiomyopathy

Edelson, J. B., Stanley, H. M., Min, J., Burstein, D. S., Lane-Fall, M. B., O’Malley, S., Shah, M. J., McBride, M. G., Stephens, P., Griffis, H. M., et al. (2022) · JACC Advances · doi:10.1016/j.jacadv.2022.100107 · Cited by 13

Papillary-Muscle-Derived Radiomic Features for Hypertrophic Cardiomyopathy versus Hypertensive Heart Disease Classification

Liu, Q., Lu, Q., Chai, Y., Tao, Z., Wu, Q.-Z., Jiang, M., & Pu, J. (2023) · Diagnostics · doi:10.3390/diagnostics13091544 · Cited by 13

The Importance of Left Ventricular Outflow Tract and Mid-Ventricular Gradients in Stress Echocardiography: A Narrative Review

Cotrim, C., Pálinkás, E. D., & Cotrim, N. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12165292 · Cited by 13

Natural History and Clinical Outcomes of Patients with Hypertrophic Cardiomyopathy from Thin Filament Mutations

Saul, T., Bui, Q. M., Argirò, A., Keyt, L. K., Olivotto, I., & ADLER, E. D. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14848 · Cited by 12

Sudden Cardiac Death in Athletes.

Tsang, D. C., & Link, M. S. (2021) · PubMed Central · doi:10.14503/thij-20-7513 · Cited by 2

Ablação Septal com Cateteres e Radiofrequência Guiada pela Ecocardiografia para Tratamento de Pacientes com Cardiomiopatia Hipertrófica Obstrutiva: Experiência Inicial

Valdigem, B. P., Correia, E. B., Moreira, D. A. R., Bihan, D. C. D. S. L., Pinto, I. M. F., Abizaid, A., Andalaft, R. B., Paladino, A. T., da Silva, H. A. G. P., & Viesi, J. H. Z. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200732 · Cited by 12

The Role of Multimodality Imaging in Pediatric Cardiomyopathies

Moscatelli, S., Leo, I., Bianco, F., Borrelli, N., Beltrami, M., Garofalo, M., Milano, E., Bisaccia, G., Iellamo, F., Bassareo, P., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144866 · Cited by 12

Premature Ventricular Contraction-Induced Cardiomyopathy: Contemporary Evidence from Risk Stratification, Pathophysiology, and Management

Attachaipanich, T., Thiravetyan, B., Tribuddharat, N., Jaroonpipatkul, S., & Navaravong, L. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13092635 · Cited by 11

Arrhythmia Monitoring for Risk Stratification in Hypertrophic Cardiomyopathy

Du, D., Li, C. O. Y., Ong, K., Parsa, A., Weissler‐Snir, A., Geske, J. B., & Laksman, Z. (2022) · CJC Open · doi:10.1016/j.cjco.2022.01.001 · Cited by 11

Usefulness of Longitudinal Strain Adjusted to Regional Thickness in Hypertrophic Cardiomyopathy

Urtado, S., Hergault, H., Binsse, S., Aïdan, V., Ouadahi, M., Szymanski, C., Mallet, S., Hauguel‐Moreau, M., Carlier, R., Dubourg, O., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11082089 · Cited by 11

Comparison of left ventricular global and segmental strain parameters by cardiovascular magnetic resonance tissue tracking in light-chain cardiac amyloidosis and hypertrophic cardiomyopathy

Wang, F., Xu, X., Wang, Q., Yu, D., Lv, L., & Wang, Q. (2022) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-22-329 · Cited by 11

Inequities in Treatments and Outcomes Among Patients Hospitalized With Hypertrophic Cardiomyopathy in the United States

Johnson, D. Y., Waken, R. J., Fox, D. K., Hammond, G., Maddox, K. E. J., & Cresci, S. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.029930 · Cited by 11

Safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of aficamten in healthy Chinese participants: a randomized, double-blind, placebo-controlled, phase 1 study

Zhao, X., Liu, H., Tian, W., Fang, L., Yu, M., Wu, X., Liu, A., Wan, R., Li, L., Luo, J., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1227470 · Cited by 11

Evaluation of the relationship between left atrial strain and exercise tolerance in patients with hypertrophic cardiomyopathy by treadmill stress echocardiography

Su, Y., Li, C., & Yin, L. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1168514 · Cited by 10

Myocardial Characterization on CT: Late Iodine Enhancement and Extracellular Volume

Bartoli, A., Gnasso, C., Palmisano, A., Bettinelli, A., Vignale, D., & Esposito, A. (2025) · Echocardiography · doi:10.1111/echo.70108 · Cited by 10

Arrhythmias and Sudden Death: What is New in Hypertrophic Cardiomyopathy?

Rajan, D., Zörner, C. R., Hansen, M. L., & Tfelt‐Hansen, J. (2025) · Cardiac failure review · doi:10.15420/cfr.2024.38 · Cited by 10

Selection of patients eligible for implantable cardioverter defibrillator: beyond left ventricular ejection fraction

Rizzello, V. (2022) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suac087 · Cited by 10

Long-term outcomes of surgery for obstructive hypertrophic cardiomyopathy in a pediatric cohort

Nguyen, S. N., Chung, M., Vinogradsky, A., Richmond, M. E., Zuckerman, W. A., Goldstone, A. B., & BACHA, E. A. (2023) · JTCVS Open · doi:10.1016/j.xjon.2023.09.032 · Cited by 10

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy

Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.045 · Cited by 643

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001250 · Cited by 807

The Wait is Over: The 2020 American Heart Association/American College of Cardiology (AHA/ACC) Hypertrophic Cardiomyopathy Guidelines Have Arrived

Semsarian, C., & Davis, L. (2021) · Heart Lung and Circulation · doi:10.1016/j.hlc.2021.02.002 · Cited by 1

Hypertrophic cardiomyopathy: a practical approach to guideline directed management

Ommen, S. R., & Semsarian, C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01205-8 · Cited by 92

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy

Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K., Evanovich, L., Ferrari, V. A., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.02.014 · Cited by 425